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Summary
Acyl-CoA synthetase-1 (ACSL) contributes 80% of total ACSL activity in adipose tissue and was
believed to be essential for the synthesis of triacylglycerol. We predicted that an adipose-specific
knockout of ACSL1 (Acsl1A−/−) would be lipodystrophic, but, compared to controls, Acsl1A−/−
mice had 30% greater fat mass when fed a low fat diet, and gained weight normally when fed a
high fat diet. Acsl1A−/− adipocytes incorporated [14C]oleate into glycerolipids normally, but fatty
acid oxidation rates were 50–90% lower than in control adipocytes and mitochondria. Acsl1A−/−
mice were markedly cold intolerant, and β3-adrenergic agonists did not increase oxygen
consumption, despite normal adrenergic signaling in brown adipose tissue. The reduced adipose
FA oxidation and marked cold intolerance of Acsl1A−/− mice indicate that normal activation of FA
for oxidation in adipose tissue in vivo requires ACSL1. Thus, ACSL1 has a specific function in
directing the metabolic partitioning of fatty acids towards β-oxidation.
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Introduction
Dysfunctional lipid metabolism underlies the development of obesity and obesity-related
complications such as hepatic steatosis, diabetes, and heart disease. Although the
mechanisms that regulate the cellular uptake, activation, and metabolism of fatty acid (FA)
are not fully understood, nearly all pathways of FA metabolism require the acyl-CoA
synthetase–mediated conversion of FAs to acyl-CoAs (FA + CoA + ATP → acyl-CoA +
AMP + PPi). Acyl-CoAs have multiple fates, including use in complex lipid formation and
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lipid remodeling, effects on signal transduction, activation of transcription factors, and
oxidation to provide cellular energy. Long-chain acyl-CoAs are formed by a family of five
acyl-CoA synthetases (ACSL), ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6, and by
several fatty acid transport proteins (FATP). ACSL isoenzymes are intrinsic membrane
proteins whose active sites face the cytosol to produce acyl-CoAs which are either
partitioned into the facing membrane monolayer where they can encounter downstream
metabolic enzymes (Coleman and Bell, 1978; Mannaerts et al., 1982), or transported to
different organelles by the cytosolic acyl-CoA binding protein (Stremmel et al., 2001). The
ability of amphipathic acyl-CoAs to move freely within a single membrane monolayer or to
be transported to distant membranes should render all acyl-CoAs metabolically equivalent,
no matter which ACSL isoenzyme catalyzes their formation. Yet, gain-of-function studies
suggest that each of the ACSL isoform has a distinct function in directing acyl-CoAs to one
or more specific downstream pathways (Li et al., 2006; Mashek et al., 2006b).
The functions of the ACSLs are of particular interest in adipose tissue because of the central
role that white adipose tissue (WAT) plays in energy storage and that brown adipose tissue
(BAT) plays in energy dissipation. In WAT, Acsl1 mRNA is the most abundantly expressed
isoform, with relatively lower expression of Acsl3, -4, and -5 (Mashek and Coleman, 2006).
Acsl1 mRNA in liver is upregulated by PPARα ligands (Martin et al., 1997), whereas its
mRNA in WAT is increased by PPARγ agonists (Gerhold, 2002; Shimomura et al., 1993).
In differentiating 3T3-L1 adipocytes, ACSL specific activity and mRNA expression increase
100- and 160-fold, respectively (Coleman et al., 1978; Marszalek et al., 2004), whereas the
expression of the other Acsl isoenzymes remains unchanged (Oikawa et al., 1998). This
induction of Acsl1 expression suggested that ACSL1 is upregulated as part of the program of
adipocyte differentiation culminating in triacylglycerol (TAG) synthesis and storage.
Consistent with this interpretation, an expression cloning strategy designed to find cDNAs
that augment FA uptake and incorporation into TAG cloned ACSL1 (Schaffer and Lodish,
1994). Further, overexpressed ACSL1 in 3T3-L1 adipocytes increases FA uptake and
incorporation into TAG (Gargiulo et al., 1999; Richards et al., 2006; Souza et al., 2002). In
order to examine the putative role of ACSL1 in TAG synthesis, we created a mouse
deficient in adipose ACSL1, and predicted that these mice would be unable to synthesize
and store TAG in adipocytes. Surprisingly, however, the Acsl1A−/− mice had normal fat
stores, but severely impaired adipose FA oxidation, suggesting not only that ACSL1
catalyzes the initial required step in FA oxidation, but also that it specifically directs FA
towards mitochondrial β-oxidation.
Results
Generation of mice that lack ACSL1 specifically in adipose tissue
Mice with Loxp sequences inserted on either side of exon 2 in the Acsl1 gene (Li et al.,
2009) and backcrossed to the C57Bl/6 strain six times were crossed with mice in which Cre
expression is driven by the aP2 promoter [B6.Cg-Tg (Fabp4-cre) 1Rev/J; Jackson
Laboratories, Bar Harbor ME] to generate adipose-specific Acsl1 knockout mice
(Acsl1A−/−). Littermates lacking the Cre gene (Acsl1flox/flox) were used as controls.
ACSL1 protein was virtually absent in brown, gonadal, and inguinal adipose tissue from
Acsl1A−/− mice (Fig. 1A). ACSL specific activity was 80% lower than in controls,
confirming that ACSL1 is, functionally, the major ACSL in adipose tissue (Fig. 1B), with
the remaining 20% of ACSL activity catalyzed by other ACSL isoenzymes in adipocytes
and all ACS enzymes in stromovascular tissue (Mashek et al., 2006a). Confirming the
tissue-specificity of the knockdown, ACSL1 protein and total ACSL specific activity were
unaffected in Acsl1A−/− liver (Fig. 1A, B). Real-time PCR showed nearly absent expression
of Acsl1 mRNA in Acsl1A−/− gonadal and brown adipose tissue, but unchanged expression
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of the other four Acsl isoenzymes and a 50% reduction in Fatp1 mRNA, a related ACS (Fig.
1C, D). Thus, other acyl-CoA synthetases did not compensate for the loss of ACSL1.
Acsl1A−/− mice have increased fat mass and synthesize TAG normally
Despite the 80% loss of adipose ACSL activity, Acsl1A−/− mice had increased adiposity.
When fed a 10%-fat diet, Acsl1A−/− body weights were similar to controls (Fig. 2A), but
MRI analysis showed that the mice had 30% more body fat (Fig. 2B). Consistent with the
MRI data, gonadal fat depot weights were ~40% greater in mice fed chow or 10%-fat diets
(Fig. 2C). Gonadal adipose tissue histology, adipocyte size, GPAT specific activity, and
AMPK phosphorylation were similar between genotypes (Fig. 2D–G). No genotype
differences in liver or BAT weights were observed.
No diet-related differences were observed between genotypes in plasma glucose, FA,
cholesterol, or insulin concentrations (Table S1). However, plasma TAG concentrations
were 17% lower in Acsl1A−/− mice. A 45%-fat diet resulted in weight gain, adiposity, and
insulin resistance that was similar in both genotypes (Fig. 2A, Table S1). Loss of ACSL1
could theoretically change the cellular content and ratio of its FA substrate and acyl-CoA
product, thereby alter (Berger and Moller, 2002;Hostetler et al., 2005), however target genes
of these transcription factors did not change significantly in Acsl1A−/− gonadal WAT (Table
S2).
When fed a low-fat diet, the amount of phospholipid extracted from epididymal WAT was
similar in both genotypes, but Acsl1A−/− WAT contained more TAG, DAG, and FA per fat
pad (Fig. 2H). With the high-fat diet, no differences were present between control and
Acsl1A−/− lipid classes in epididymal WAT. BAT from Acsl1A−/− and control mice fed
either diet also contained similar amounts of all lipid classes (Fig. S1A, B). Thus, lack of
ACSL1 did not impair adipose TAG accumulation.
Confirming normal TAG synthesis in both isolated white gonadal adipocytes and cultured
primary white adipocytes from control and Acsl1A−/− mice, the rates of [1-14C]oleate
incorporation into TAG and phospholipid were similar, indicating that the lack of ACSL1
did not impair FA incorporation into complex lipids (Fig. 2I,J). Thus, despite greater than
100-fold increases in Acsl1 mRNA and ACSL specific activity during fat cell differentiation
(Coleman et al., 1978; Marszalek et al., 2004), TAG synthesis does not require FA
activation by ACSL1. The increased fat mass did not result from impaired lipolysis because
in 24h fasted mice and in media from white adipose tissue explants with or without exposure
to lipolytic stimuli (Fig. 2K–M, Table S3) FA and glycerol release were similar between
genotypes.
Differences in FA species content in adipose tissue
We did not expect to find major changes in FA species because each of the purified ACSL
isoenzymes in vitro can activate a wide range of long-chain, saturated and unsaturated FA
(Oikawa et al., 1998). However, compared to controls, Acsl1A−/− mice fed both the low-fat
and high-fat diets contained 20–30% less 18:2n6 in TAG from brown and gonadal white
adipose (Fig. S1C, D). The TAG fraction of BAT from Acsl1A−/− mice was composed of
15% more 16:0 than controls fed the low-fat diet (Fig. S1E). In Acsl1A−/− BAT, the PL
fraction from mice fed the high-fat diet contained 30% more 16:0 and 15%, 22%, and 14%
less 18:0, 18:2n6, and 20:4n6, respectively, than controls (Fig. S1F). No other differences in
the major fatty acid species were observed. These small, but statistically significant,
alterations in lipid composition of adipose tissues suggest that ACSL1 does contribute to the
relative content of esterified FA species in neutral lipids and phospholipids, despite the
minimal differences in FA preference observed in vitro.
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Fatty acid oxidation was impaired in white adipocytes from Acsl1A−/− mice
Compared to mature adipocytes isolated from control mice, the rate of [1-14C]oleate
incorporation into CO2 and acid soluble metabolites (ASM) was 50% lower in Acsl1A−/−
adipocytes (Fig. 2N). CO2 and ASM represent complete and incomplete products of fatty
acid oxidation; thus, the 50% reduction of FA incorporation into these oxidative products
reflects reduced β-oxidation and suggests that impaired FA catabolism could have caused
the larger WAT depots in the Acsl1A−/− mice.
Decreased FA oxidation rendered Acsl1A−/− mice cold intolerant
FA oxidation increases markedly in BAT during cold exposure. To generate heat and
maintain normal body temperature, ATP production is reduced when activated uncoupling
protein (UCP1) increases the flux of protons through the electron transport chain and
dissipates the mitochondrial proton gradient (Lowell and Spiegelman, 2000). Fasted
wildtype mice can maintain their body temperature above 35°C for as long as 24 h at 4°C
(Cohen et al., 2005). In striking contrast, however, the body temperature of the Acsl1A−/−
mice fell below 30°C within 3 h (Fig. 3A). During cold exposure, both genotypes shivered
similarly, and gastrocnemius total ACSL activity (Fig. S4A) and Acsl1 mRNA abundance
(data not shown) did not change in Acsl1A−/− mice. In shivering muscle, fuel preference and
the contribution of muscle heat to total body heat remain unclear (Haman, 2006); however,
plasma FFA and VLDL were not limiting for either Acsl1A−/− skeletal muscle or BAT (Fig.
6C, D).
Direct measurements of FA oxidation rates in BAT homogenates from Acsl1A−/− mice
showed that the rate of [1-14C]palmitate incorporation into CO2 and ASM was 36% lower
than controls (Fig. S5C). Because label dilution occurs when fatty acid oxidation is
measured in cells with a high lipid content, we confirmed this oxidation defect by
monitoring O2 consumption in conscious Acsl1A−/− and control mice in Oxymax chambers.
Whole body O2 consumption normally increases in response to adrenergic stimuli and
reflects an increase in electron transport chain activity. Isoproterenol, a non-specific β-
adrenergic receptor agonist, increased O2 consumption 51% in control mice, but only 18%
in Acsl1A−/− mice (Fig. 3B). This blunted response indicates that whole body oxidation is
diminished. When CL-316243, an adipose-specific, β3-adrenergic receptor agonist (Yoshida
et al., 1994) was injected, O2 consumption increased 30% in control mice, but only 2% in
Acsl1A−/− mice, showing that the block in adrenergic-mediated oxidation was adipose-
specific (Fig. 3B,S5B).
In mitochondria from Acsl1A−/− BAT, the production of CO2 from [1-14C]palmitate
oxidation was reduced 62% (Fig. 3E,G), and this reduction in mitochondrial FA oxidation
correlated directly with the amount of mitochondrial ACS activity and ACSL1 protein
present in each of three mitochondrial preparations (Fig. 3F,S4F,E). In contrast, CO2
production from [1-14C]pyruvate oxidation was similar to that of control mitochondria,
showing that Acsl1A−/− BAT mitochondria are functional for substrates other than FA. The
31% reduction in [1-14C]palmitoyl-CoA oxidation (Fig. 3G) suggests that FA oxidation may
require the generation of acyl-CoA at the mitochondrial membrane, and/or that the
mechanism by which ACSL1 directs its acyl-CoA product towards mitochondrial oxidation
may be partially disrupted by homogenization. The rate of oxygen consumption in control
and Acsl1A−/− BAT mitochondria was similarly increased by UCP1-dependent pyruvate
stimulation and, in both genotypes, GDP effectively reduced oxygen consumption by
inhibiting UCP1 (Fig. S4). These data show that ACSL1 deficient BAT mitochondria have
full UCP1 activity and that Acsl1A−/− cold intolerance is not due to impaired UCP1 function.
Taken together, these data from live mice, BAT homogenates, and isolated mitochondria
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indicate that cold intolerance of the Acsl1A−/− mice resulted from impaired FA oxidation and
show that ACSL1 is absolutely required for cold-adaptive thermogenesis in BAT.
After 4 h at 4°C, BAT from control mice depleted its lipid droplets, but lipid droplets were
retained in Acsl1A−/− BAT (Fig. 3C). Control mice lost ~50% of BAT lipid stores after 4 h
of cold exposure, whereas the TAG content in Acsl1A−/− BAT did not change (Fig. 3D).
Liver and WAT histology was similar at 21°C and 4°C in both genotypes (data not shown).
Although TAG retention in Acsl1A−/− BAT after cold exposure could be due to impaired
lipolysis, the increase in plasma FA and glycerol in cold-exposed Acsl1A−/− mice is
consistent with active TAG lipolysis in WAT (Fig. 6B,C), and in differentiated primary
brown adipocytes from Acsl1A−/− mice, the release of FA into the media was greater than
controls under basal conditions and similar after adrenergic stimuli, demonstrating that
Acsl1A−/− brown adipocytes lipolyzed intracellular triacylglycerol normally (Fig. 3I).
Surprisingly, compared to control cells, glycerol release in Acsl1A−/− brown adipocytes was
blunted by ~50% after adrenergic stimulation (Fig. 3H). Reduced release of glycerol by
Acsl1A−/− brown adipocytes could result from increased conversion to glycerol-3-P for lipid
synthesis or because the glycerol was oxidized as an alternative substrate. After 3 h of
isoproterenol exposure, both Acsl1A−/− and control differentiated brown adipocytes had
similar ~33% reductions in [14C]oleate-labeled TAG (Fig. 3J), indicating that both lipolysis
and FA re-esterification after lipolysis were unaffected by ACSL1 deficiency. [1-14C]Oleate
incorporation into ASM was 90% lower in Acsl1A−/− brown adipocytes than in controls,
consistent with the marked decrease in FA oxidation (Fig. 3K). Thus, in cold-exposed
Acsl1A−/− BAT, the retention of lipid droplets probably reflects an influx of FA that cannot
be oxidized without ACSL1 and are, therefore, incorporated into neutral lipid.
Thermogenic regulation of adrenergic and oxidative genes was normal in Acsl1A−/− mice
β-adrenergic signaling during cold exposure induces the expression of genes that activate
mitochondrial biogenesis, heat production, and oxidative capacity. At 4°C both control and
Acsl1A−/− mice upregulated mRNA levels of Ucp1 and PPAR-γ coactivator-1α (Pgc1α) 2-
and 30- fold, respectively (Fig. 4A,B). These increases indicate that adrenergic-stimulated
signaling was unimpaired in Acsl1A−/− BAT (Bachman et al., 2002).
Compared to controls, the mRNA expression of muscle-type carnitine
palmitoyltransferase-1 (mCpt1) was significantly higher in the Acsl1A−/− BAT at 21°C, and
cytosolic thioesterase-1 (Cte1) was significantly higher after cold exposure, suggesting that
the lack of ACSL1 might increase cellular FA to activate PPARα-mediated transcription
(Fig. 4C). However, the expression of other PPARα-regulated genes, medium-chain acyl-
CoA dehydrogenase (Mcad), acyl-CoA oxidase (Aox), and Ppara, did not differ between the
genotypes, suggesting that the lack of ACSL1 does not affect all PPARα target genes with or
without 4 h of cold exposure.
Because Acsl1A−/− BAT retained lipid droplets after cold exposure, we measured genes that
encode lipogenic and substrate-producing proteins that would normally increase during cold
exposure. Acsl1A−/− BAT should have been able to lipolyze and/or endocytose circulating
TAG-rich lipoproteins and to make use of these exogenous FA sources, because the
lipogenic genes lipoprotein lipase (Lpl) and VLDL-receptor (Vldl-r) had similar expression
patterns with or without cold exposure in both genotypes (Fig. 4D). Similarly, 1-
acylglycerol-3-phosphate O-acyltransferase- 1 (Agpat1) increased in both genotypes, as did
Gpat4, a major GPAT in BAT (Vergnes et al., 2006). These data suggest that the retained
lipid droplets in Acsl1A−/− BAT were not caused by abnormal regulation of genes required
for TAG synthesis.
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BAT expression of Acsl3 and Acsl4 (but not Acsl1, Acsl5, or Acsl6) was upregulated in both
genotypes in response to cold (Fig. 4E), and long-chain acyl-CoA content in cold exposed
Acsl1A−/− BAT did not differ from controls (Fig. 6E). These data indicate that acyl-CoAs
synthesized by other ACSL isoenzymes were unavailable for β-oxidation and that
maintenance of normal body temperature requires acyl-CoAs synthesized by ACSL1.
Acyl-carnitines were reduced in Acsl1A−/− BAT
To gain further insight into the consequences of ACSL1 deficiency, we used mass
spectrometry to profile a targeted array of intermediary metabolites. Long-chain acyl-
carnitines accumulate when their production by mitochondrial CPT1 exceeds their flux
through β-oxidation (Makowski et al., 2009). In wild type mice, cold exposure lowered
major long-chain acyl-carnitine species and increased β-hydroxybutyryl-carnitine (4-OH), a
strong marker of increased β-oxidation and ketone metabolism (Figs. 5A–C, S2B). This
profile is consistent with activation of mitochondrial uncoupling and a shift in flux limitation
from long-chain acyl-CoA dehydrogenase to short-chain β-hydroxy-acyl-CoA
dehydrogenase. In contrast, under thermoneutral conditions, BAT concentrations of most
long-chain acyl-carnitine species were markedly lower in Acsl1A−/− mice compared to
controls. Taken together with our measures of FA oxidation, this finding suggests impaired
delivery of long-chain acyl-CoAs to CPT1. During cold exposure, although Acsl1A−/− BAT
had increases in several long- and short-chain acyl-carnitines, these remained substantially
lower than in controls (Figs. 5A–C, S2B,C). BAT levels of acetyl-carnitine (C2), which is
derived from acetyl-CoA, were similar between genotypes, suggesting that increased
catabolism of glucose and/or amino acids in the Acsl1A−/− mice partially compensated for
impaired FA oxidation.
In control mice the BAT content of most organic acids was maintained during cold
exposure, with the exceptions of lactate and succinate which declined (Fig. 5D–F).
Compared to controls, lactate was lower in Acsl1A−/− mice, regardless of temperature,
consistent with enhanced pyruvate oxidation and a shift in cellular redox state. The lower
levels of succinate in Acsl1A−/− BAT may reflect disinhibition of succinate dehydrogenase
(complex II). Notably, BAT levels of several amino acid-derived CoA species (propionyl-
CoA, succinyl-CoA, 3-methylcrotonyl-CoA, isovaleryl-CoA) were elevated in Acsl1A−/−
compared to control mice, principally during cold exposure (Fig. 5G,H). These elevations
are consistent with a compensatory increase in protein catabolism and amino acid oxidation.
Supporting this interpretation, the concentrations of branched chain and anaplerotic amino
acids (valine, leucine/isoleucine, tyrosine) were elevated in the Acsl1A−/− mice, whereas
alanine, the major gluconeogenic amino acid, was decreased (Fig. 5I,J).
Hypoglycemia and hyperlipidemia in Acsl1A−/− mice after adrenergic stimuli
Plasma glucose decreased in both genotypes during cold exposure, however, the plasma
glucose concentration in Acsl1A−/− mice fell 58% more than in the controls (Fig. 6A).
Similarly, after β-adrenergic stimulation with isoproterenol or CL-316243, Acsl1A−/− plasma
glucose was 36% or 19% lower, respectively, than controls. The larger decrements in
glucose in Acsl1A−/− mice after cold exposure and β-adrenergic agonists, but not after 24 h
of fasting (Table S3), suggest enhanced glucose use by Acsl1A−/− BAT. Plasma glycerol
increased similarly in both genotypes, both during cold exposure and after isoproterenol
injection; however, in response to CL-316243, circulating glycerol increased 14% in
controls, but decreased 15% in Acsl1A−/− mice, consistent with the reduced glycerol release
by Acsl1A−/− primary brown adipocytes (Fig. 3H). Again, the glycerol decrease in BAT may
reflect its increased use as an alternate oxidative substrate (Fig. 6B). FA concentrations after
cold exposure or CL-316243 were 30% higher in Acsl1A−/− mice compared to controls (Fig.
6C); this increase in plasma FA induced by β-adrenergic stimuli, but not after 24 h of
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fasting, provides additional evidence for intact Acsl1A−/− lipolytic activity and is consistent
with diminished use of FA for oxidation in BAT. In response to cold exposure, plasma
TAG, another potential source of FA for BAT metabolism, decreased 41% in control mice,
but was unchanged in Acsl1A−/− mice despite elevated Lpl mRNA (Figs. 6D, 4E), probably
as a result of hepatic recycling of the elevated plasma FA into VLDL.
Discussion
After a long-chain FA enters a cell, its metabolic fate is determined by the metabolic
demands of the cell, the availability of other energy substrates, PPARα- and PPARγ-
mediated changes in enzymes of complex lipid synthesis and β-oxidation (Qi et al., 2000),
and the relative content of intracellular AMP which controls AMP-activated kinase and,
thus, CPT1 (Ruderman et al., 2003). Here we show that ACSL1 contributes critically to
adipose FA metabolism by catalyzing the formation of acyl-CoAs that are used for β-
oxidation. If all acyl-CoAs were metabolically equivalent, one would expect that the rates of
acyl-CoA incorporation into all metabolic end products would be diminished equally and
that adipose from Acsl1A−/− mice would have impairments in both FA oxidation and
complex lipid synthesis. However, the role of adipose ACSL1 in catalyzing the key initial
step in FA oxidation is supported by the normal rate of FA incorporation into complex lipids
and the 50–90% reduction in the rate of FA oxidation in white and brown adipocytes and in
BAT mitochondria from Acsl1A−/− mice, together with the inability of Acsl1A−/− BAT to
oxidize FA for thermogenesis. Although the content of acyl-CoA in BAT was similar in
control and Acsl1A−/− mice, these acyl-CoAs were unavailable for β-oxidation in the
absence of ACSL1. The inability of the other ACSL isoenzymes to direct acyl-CoAs
towards β-oxidation, especially during the physiological stress of acute cold exposure in
BAT, indicates that ACSL1 has a distinct function in partitioning FA, and that the other
ACSL isoenzymes in adipose tissue cannot compensate for its absence. Our data also
suggest that the importance of FA oxidation in WAT has been underestimated.
Acute cold exposure stimulates norepinephrine release, which induces adipocyte TAG
lipolysis via β-adrenergic receptors (Fig. 7). In BAT, lipolyzed FA activates UCP1 to
dissipate the mitochondrial proton gradient; activation of UCP1 results in energy expended
in the form of heat rather than ATP generation. Thermogenesis is maintained primarily
through FA oxidation; glucose cannot maintain euthermia at 4°C in knockout mice deficient
in short-chain-, medium-chain-, long-chain-, or very-long-chain acyl-CoA dehydrogenases
(Guerra et al., 1998;Schuler et al., 2005;Tolwani et al., 2005). When Acsl1A−/− mice were
exposed to a 4°C environment, their body temperature dropped below 30°C within 2 to 5 h,
despite the normal increase in BAT catecholamine-regulated genes. Because no method
exists to distinguish between FA and acyl-CoAs as activators of UCP1 (Strieleman et al.,
1985;Strieleman and Shrago, 1985), the actual activator of UCP1 could be acyl-CoA
generated by ACSL1. If this were true, Acsl1A−/− mice would be cold intolerant because
UCP1 is not activated. However, impaired acyl-CoA oxidation was observed directly in
BAT mitochondria, brown primary adipocytes, and BAT homogenates, and in isolated
gonadal adipocytes which do not require UCP1 activation. In addition, compared to control
mice, the in vivo rate of oxygen consumption of Acsl1A−/− mice at 21°C was 60% lower, and
when stimulated by isoproterenol or by an adipose-specific β3 adrenergic receptor agonist,
was more than 90% lower, indicating reduced flux through the electron transport chain and
reduced adipose mitochondrial oxidation. Finally, Acsl1A−/− UCP1 uncoupling was
activated by pyruvate and inhibited by GDP, indicating normally activated UCP1 (Fig. S4)
(Shabalina et al., 2004).
The role that FA oxidation plays in WAT has not been extensively investigated (Deveaud et
al., 2004). Apart from the normal demands of cellular metabolism, adipocytes require
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energy both to synthesize FA de novo and to activate FA to acyl-CoAs for TAG synthesis.
Our data show that the loss of ACSL1 in WAT reduced FA oxidation 50% and resulted in a
30% increase in adipose mass. Although it is possible that ACSL1 is not the sole isoform in
WAT that can activate the FA that is targeted towards β-oxidation, we attribute the increased
WAT mass in Acsl1A−/− mice to diminished use of FA for energy generation within WAT
itself, because mice that cannot use BAT for thermogenesis are not obese unless they are
kept at a thermoneutral temperature (Lodhi and Semenkovich, 2009). The potential
importance of FA β-oxidation in WAT is supported by the observation that mitochondrial
proteins increase 20- to 30-fold in WAT after treatment with a PPARγ agonist or during
3T3-L1 adipocyte differentiation (Shi et al., 2008; Wilson-Fritch et al., 2003). The
physiological stimuli that increase the rate of FA oxidation in WAT are unknown, but
treating 3T3-L1 cells with an adipocyte-differentiation cocktail plus rosiglitazone increases
the content of both mitochondrial ACSL1 protein and proteins required for FA oxidation,
suggesting coordinated regulation (Wilson-Fritch et al., 2004).
The AMP generated by the ACSL1 reaction may activate AMP kinase in 3T3-L1 adipocytes
stimulated with isoproterenol or forskolin (Gauthier et al., 2008; Lobo et al., 2009).
However, AMPK phosphorylation was not altered in Acsl1A−/− WAT (Fig. 2F), and acute
cold exposure does not activate AMPK in BAT (Mulligan et al., 2007). Thus AMPK activity
does not mediate the cold intolerance of Acsl1A−/− mice. When RNAi was used to
knockdown ACSL1 in 3T3-L1 adipocytes (Lobo et al., 2009), the cells increased FA efflux
during lipolysis, suggesting that ACSL1 activates and re-esterifies FA that has been
lipolyzed from intracellular TAG. Our results suggest a different function. If reesterification
were impaired in Acsl1A−/− adipose, one would expect that an acute cold challenge would
deplete TAG stores in BAT and that WAT would contain less TAG. However, Acsl1A−/−
mice retained their BAT lipid stores at 4°C, suggesting that reesterification was not
diminished. Further, in Acsl1A−/− primary brown adipocytes, loss of [14C]- labeled FA in
TAG after lipolytic stimuli was similar to controls, and in white adipose explants, the release
of FA and glycerol was similar between genotypes with or without lipolytic stimuli.
Although the increased release of FA from brown adipocytes (Fig. 3I) could suggest
diminished reesterification under basal conditions, both genotypes had similar losses of
[14C]oleate that had been incorporated into TAG and in the release of FA under lipolytic
conditions. These data confirm normal rates of lipolysis and, together with the cold
intolerance and increased adipose mass of the Acsl1A−/− mice, are consistent with normal
FA reesterification. In fact, a proteomics study demonstrates marked differences in the
protein expression of mitochondria from 3T3-L1 adipocytes and those from primary mouse
adipocytes, so it is not surprising to find functional differences in these two cell types
(Forner et al., 2009; Lobo et al., 2009).
Based on the dramatic increase in Acsl1 mRNA and total ACSL activity in differentiating
3T3-L1 adipocytes (Coleman et al., 1978; Marszalek et al., 2004), we had predicted that
adipocyte ACSL1 would catalyze the synthesis of acyl-CoAs destined for TAG synthesis.
However, both mature and primary differentiated white adipocytes from Acsl1A−/− mice
incorporated [14C]oleate into TAG normally, and Acsl1A−/− fat depots were larger than
those of controls. Further, Acsl1A−/− mice became obese and insulin resistant when fed a
high-fat diet. Although the lack of ACSL1 in white and brown adipose tissue reduced ACSL
specific activity by 80%, the remaining ACSL activity, derived from other ACSL and FATP
isoenzymes, was able to synthesize acyl-CoAs directed towards normal TAG biosynthesis.
Thus, ACSL1 is not required for TAG synthesis in adipose tissue.
How does ACSL1 channel acyl-CoAs towards β-oxidation? In adipocytes, subcellular
fractionation studies identified ACSL1 on the plasma membrane, microsomes and
mitochondria (Gargiulo et al., 1999), on GLUT4 vesicles (Sleeman et al., 1998), and on lipid
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droplets (Brasaemle et al., 2004). In BAT and WAT ACSL1 protein has also been found in
mitochondria fractions (this ms; (Forner et al., 2009)). However, even if ACSL1 were
located solely on the mitochondrial outer membrane, its ability to channel its acyl-CoA
product towards β-oxidation remains difficult to conceptualize. Long-chain acyl-CoAs are
water-soluble, amphipathic molecules that can partition into membranes or bind to cytosolic
carriers like acyl-CoA binding protein. Thus, acyl-CoAs should be able to move freely
within the membrane monolayer at their site of synthesis, and to travel between different
organelles. Direct physical interaction of ACSL1 with other proteins, such as CPT-1, is the
most likely explanation for acyl-CoA channeling, but evidence for such interaction is
lacking.
In summary, the loss of ACSL1 in adipose tissue produced mice with increased adiposity
and severe cold intolerance. Adipocytes derived from Acsl1A−/− mice had normal rates of
FA incorporation into TAG and normal loss of TAG stores after lipolysis, but had reduced
rates of FA oxidation. Although deficient ACSL1 in liver, which expresses relatively more
of the ACSL4 and ACSL5 isoenzymes, results in only a minor defect in FA oxidation (Li et




Acsl1A−/− and littermate Acsl1flox/flox control mice were housed in a pathogen-free barrier
facility (12 h light/dark cycle) in accordance with the UNC IACUC, with free access to
water and food (Prolab RMH 3000 SP76 chow). For the diet study, mice were fed a low-fat
(10%) diet (D12450B, Research Diets) or a high-fat (45%, primarily from lard) diet
(D12451) ad libitum from age 8 to 25 wk. Weights were measured weekly. Body fat mass
was assessed by magnetic resonance imaging analysis (EchoMRI-100, Echo Medical
Systems, LLC) in 5 mo old mice. For thermogenesis experiments, mice were fasted for 4 h
and placed in a 4°C environment without food. Temperature was measured hourly with a
rectal probe thermometer (Thermalert TH-5, physitemp). Mice were removed from the cold
when core temperature dropped below 28°C or at 4 h. Rates of O2 consumption were
determined in Oxymax chambers (Columbus Instruments) after mice were acclimated
overnight. Data were collected from mice for 3 h after saline injection. After isoproterenol
or CL-316243 was injected (10 mg/kg), O2 consumption was measured for an additional 3 h,
and then plasma was collected in 5% 0.5 M EDTA. Plasma TAG, beta-hydroxybutyrate
(Stanbio), cholesterol, FFA, glucose (Wako), and free and total glycerol (Sigma) were
measured colorimetrically. Adiponectin was measured by ELISA (Linco). Oral glucose
tolerance tests were performed by gavaging with glucose (2.5 mg/kg body weight) and
measuring tail blood glucose at baseline, 15, 30, 60, and 120 minutes (One Touch Ultra
glucometer, Lifescan, Inc).
Enzyme Assays
ACSL initial rates were measured with 50 µM [1-14C]palmitic acid, 10 mM ATP, and 0.25
mM CoA with total membrane fractions (0.5–4.0 µg) (Polokoff and Bell, 1978). GPAT was
measured with 800 µM [3H]glycerol-3-phosphate and 82.5 µM palmitoyl-CoA (Nagle et al.,
2008).
Adipocyte studies
Adipose explants were isolated and release of FFA and glycerol was measured (Warne et al.,
2006). Epididymal adipocytes were isolated (Varma et al., 2008). Rates of CO2 and ASM
production from [1-14C]oleate (Perkin Elmer) were measured in aliquots of the reaction
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mixture after incubating with 0.5 mL buffer containing 10 µM [1-14C]oleate for 1.5 h in a
10% adipocyte solution. The incubation chamber contained a center well filled with filter
paper and was sealed with a rubber stopper. Carbon dioxide was trapped by adding 200 µl
70% perchloric acid to the reaction mixture and 300 µl of 1 M NaOH to the center well, and
incubating the samples at RT for 45 min. The center well was then placed into scintillation
fluid and counted. The acidified reaction mixture was incubated overnight at 4°C and
centrifuged at 4,000 rpm for 30 min before aliquots of the supernatant were counted for
[14C]-labeled ASM. For FA incorporation, a 10% adipocyte solution was incubated with 0.5
mL buffer containing 10 µM [1-14C]oleate and 90 µM unlabeled oleate for 2 h. Brown and
white pre-adipocytes from control and Acsl1A−/− adipose tissue (Cao et al., 2001) were
differentiated into adipocytes for 7–14 days and exposed to 500 µM oleate with 0.6 µCi
[1-14C]oleate per 60 mm dish for 3 hours. Cells were then harvested or labeled media was
removed, replaced with growth media for 21 hours and cells were harvested or 10 µM
isoproterenol was added to media for an additional 3 hours followed by harvest. FA released
into the media were measured colorimetrically (Wako) in unlabeled control plates. Total
lipid was extracted from the cells into CHCl3 (Bligh and Dyer, 1959). The lipid extract was
dried under N2, resuspended in CHCl3 and chromatographed with authentic lipid standards
run in parallel on 0.25-mm silica gel G plates in hexane:ethyl ether:acetic acid (80:20:1; v/
v). The 14C-labeled lipids were detected and quantified with a Bioscan 200 Image System.
Fatty acid oxidation in BAT
Freshly isolated BAT was minced and homogenized with a motor-driven Teflon pestle and
glass mortar in ice-cold buffer A (100 mM KCl, 40 mM Tris·HCl, 10 mM Tris base, 5 mM
MgCl2·6H2O, 1 mM EDTA, and 1 mM ATP, pH 7.4) at a 20-fold dilution (wt/vol) or
mitochondria was isolated (Cannon and Nedergaard, 2008), resuspended in buffer A and the
rate of [1-14C]palmitate, [1-14C]palmitoyl-CoA, or [1-14C]pyruvate, was measured (Noland
et al., 2007). Isolated BAT mitochondria (20 µg protein) in buffer (70 mM sucrose, 220 mM
mannitol, 10 mM KH2PO4, 2 mM MgCl2, 2 mM HEPES, 1 mM EDTA, 0.1% BSA, 3 mM
malate, and 1.3 µg/mL oligomycin) were loaded onto XF24 plates and rates of O2
consumption were measured according to the manufacturer’s instructions with a Seahorse
X24F Analyzer (Seahorse Bioscience) during the consecutive addition at 4 min intervals of
5 mM pyruvate, 2 mM GDP, and 1 µM FCCP.
Highlights
• Adipose knockout of long-chain acyl-CoA synthetase 1 decreases ACS activity
80%
• Mice lacking ACSL1 are cold intolerant
• ACSL1 activates fatty acids that are directed towards β-oxidation
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Abbreviations
ACSL long-chain acyl-CoA synthetase
ASM acid soluble metabolites
BAT brown adipose tissue
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UCP1 uncoupling protein one
WAT white adipose tissue
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Figure 1. Generation of mice that lack ACSL1 specifically in adipose tissue
A) Representative immunoblot against ACSL1 protein and B) ACSL activity in control and
Acsl1A−/− liver, brown, gonadal, and inguinal adipose of 20 wk old mice, n=5–7. ACSL
isoenzyme mRNA expression in C) gonadal adipose and D) brown adipose from 20 wk old
control and Acsl1A−/− mice, n=6. Data represent mean ± SEM; *, P≤0.05 versus control.
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Figure 2. Acsl1A−/− mice have increased fat mass
A) Body weight from 6 to 24 weeks of age in mice fed LFD or HFD, n=10–15. B) Total
body fat measured by MRI in 26 wk old control and Acsl1A−/− male mice, n=5–7. C) Fat
depot weight as a percent of body weight (BW) in 20–26 wk old control and Acsl1A−/− male
mice, n=10–15. D) Representative sections from control and Acsl1A−/− epididymal WAT
and E) mean cells size from sections stained for hematoxylin and eosin, scale bars = 50 µM.
F) AMPK phosphorylation, relative to total AMPK, from control and Acsl1A−/− inguinal
adipose, n=4–5. G) Total GPAT activity in control and Acsl1A−/− gonadal adipose, n=6. H)
Lipid content of control and Acsl1A−/− epididymal WAT in 6 mo old male mice fed LFD or
HFD diet for 4.5 mo, n=5. [1-14C]Oleate incorporation into (I) glycerolipids or (N) acid
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soluble metabolites (ASM) and carbon dioxide (CO2), n=3–4, by control (C) and Acsl1A−/−
(A−/−) mature epididymal adipocytes, n=6. J) [1-14C]Oleate incorporation into (I)
glycerolipids by control and Acsl1A−/− cultured primary adipocytes. K) Plasma FA in
control and Acsl1A−/− mice fasted for 4 or 24 hours, n=6–8. Release of (L) FA or (M)
glycerol from control and Acsl1A−/− gonadal adipocyte explants basally or with 10µM
isoproterenol (Iso), n=8. HFD, high-fat diet; LFD, low-fat diet; TAG, triacylglycerol; DAG,
diacylglycerol; PL, phospholipids; FA, fatty acids. Data represent mean ± SEM *, P≤0.05
versus control; # P≤0.05 chow or LFD versus HFD within genotype.
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Figure 3. Acsl1A−/− mice are cold intolerant due to impaired FA oxidation
A) Body temperature of fasted control and Acsl1A−/− male mice exposed to a 4°C
environment for 4 h, n=14–16. B) Control and Acsl1A−/− male mouse O2 consumption was
monitored in a metabolic chamber for 3 h before and after injection of isoproterenol (Iso) or
CL-316243 (CL) (10 mg/kg), n=6–8. C) Representative BAT histology stained for
hematoxylin and eosin in control and Acsl1A−/− mice before and after cold exposure for 2–4
h when Acsl1A−/− body temperature reached 30°C; scale bars = 50 µm. D) TAG content of
BAT from control and Acsl1A−/− mice fasted at 21°C or at 4°C for 4 h, n=5–6. BAT
mitochondrial (E,F) [1-14C]palmitate and (G) [1-14C]palmitoyl-CoA and [1-14C]pyruvate
oxidation into carbon dioxide (CO2) from control and Acsl1A−/− mice, n=3. F) Control (C)
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and Acsl1A−/− (A−/−) ACSL1 immunoblot and protein, and CO2 production from
[1-14C]palmitate by 3 mitochondrial preparations (AC), relative to control. Control and
Acsl1A−/− cultured primary brown adipocyte release of (H) glycerol and (I) FA with or
without 10µM isoproterenol, and incorporation of [1-14C]oleate into (J) TAG and (K) ASM,
n = 3. Data represent mean ± SEM *, P≤0.05 versus control; # P≤0.05 21°C versus 4°C
within genotype.
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Figure 4. Thermogenic regulation of genes was normal in Acsl1A−/− mice
BAT mRNA levels were quantified by real-time PCR for genes of A,B) adrenergic
regulation C) FA oxidation D) lipogenesis and E) acyl-CoA synthetases in BAT from male
control and Acsl1A−/− mice without or with 4°C exposure, relative to cyclophilin A
expression, n=6. Data represent mean ± SEM; *, P≤0.05 Acsl1A−/− versus control; # P≤0.05
21°C versus 4°C within genotype. A, Agpat; G, Gpat
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Figure 5. Long-chain acyl-carnitines were reduced in Acsl1A−/− brown adipose tissue
A,B,C) Free, acetyl-, and acyl-carnitine content in BAT with and without cold exposure at
4°C. D) Lactate and, E,F) Citric acid cycle intermediates, G,H) short-chain acyl-CoA, I)
amino acids, and J) total amino acid content in BAT with and without 4°C exposure, n=7.
DC, dicarboxylated acyl-carnitines; OH, hydroxylated acyl-carnitines; Asx, aspartate/
asparagine; Gsx, glutamate/glutamine. Data represent mean ± SEM *, P≤0.05 versus
control; # P≤0.05 21°C versus 4°C within genotype (n=6–10).
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Figure 6. Plasma metabolites and BAT acyl-CoAs in Acsl1A−/− mice after adrenergic stimuli
Plasma glucose (A), glycerol (B), FA (C), and TAG (D) from control and Acsl1A−/− mice
fasted for 4 h at 21°C or 4°C, or before (T0) and 3 h after isoproterenol (Iso) or CL-316243
(CL) injection (10 mg/kg), n=6–8. E) Sum of long-chain acyl-carnitines (C14–C20) in
control (C) and Acsl1A−/− (A−/−) with or without cold exposure for 2–4 h. Data represent
mean ± SEM; *, P≤0.05 versus control; # P≤0.05 21°C or T0 versus treated within
genotype.
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Figure 7. BAT fatty acid metabolism in cold-exposed mice
When norepinephrine activates β- adrenergic receptors, activated protein kinase A (PKA)
induces PGC1α in brown adipocytes which, together with FA, activates transcription factors
that upregulate genes required for mitochondrial oxidative and thermogenic functions. PKA
also activates hormone sensitive lipase (HSL) which lipolyzes triacylglycerol (TAG) in
white and brown adipose cells. FA released from WAT and from VLDL (via lipoprotein
lipase [LPL]) enter brown adipocytes and are activated by ACSLs to form acyl-CoAs that
can be esterified to form TAG or are oxidized. FA lipolyzed from TAG stores in brown
adipocytes are activated by ACSL1, enter mitochondria, and are oxidized. FA also activate
UCP1 which uncouples the mitochondrial proton gradient, producing heat.
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